Senior Director, CMC Formulation (Watertown, MA - Onsite)

• Serve as the scientific leader in formulation, develop strategic formulation development plans in alignment with our clinical trial plans and company goals.  Design phase appropriate formulations at different stage of development (preclinical to clinical phase III)
• Manage project assignment and work distribution for formulation team
• Designs and executes pre-clinical and clinical formulation development experiments to develop and support solid and liquid oral dosage form products.
• Conducts physicochemical characterization of different drug substance lots as needed.
• Technical expertise in solid/liquid oral dosage form development and scale-up.
• Work in close collaboration with the Project and CMC teams and related functions, including discovery, non-clinical development, process development, analytical development, Quality and Regulatory teams. 
• Identify and select CDMO’s for drug product development and manufacturing.
• Manages formulation development and clinical manufacturing activities at external laboratories and manufacturing facilities. 
• Authors and reviews formulation related sections for regulatory filings, development reports and other development related documents. 
• Actively communicates, collaborates with and contributes to other functional areas to solve problems and achieve goals.
• Oversee tech transfer and future validation of drug product manufacturing processes.
• Oversee and manage CDMOs including authoring and reviewing of Batch Records/Master Production Records and specifications.
• Some travel (10-20%) required for this position.

• Advanced degree (PhD preferred) in pharmaceutical science, chemical engineering or related scientific field with 12+ years industrial drug product development experience.
• The successful candidate has demonstrated leadership in managing people, multiple projects, and budget.
• The successful candidate has a strong understanding of formulation and CMC development.
• A proven track record in developing and scaling up formulations for oral administration from pre-IND through late-stage development.
• Experience and expertise in formulation development of poorly soluble (BCS Class II/IV) compounds (small molecules).
• Extensive knowledge and hands on experience with equipment and processes commonly used for solid and liquid oral formulation development.
• Working knowledge and know-how to support preclinical studies with variety of formulation approaches and delivery routes.
• Working knowledge of methods and instrumentation used for the characterization of solution and solid-state properties of materials.
• Background in applying statistical approaches in the design and analysis of experiments and experience with Quality by Design (QbD) is preferred.
• Responsible for managing form selection/characterization, pre-formulation, formulation development, delivery of clinical supplies, development of efficient and scalable manufacturing processes.
• Excellent verbal and written communication skills, ability to effectively work across levels, functions and companies.
• Author and review drug product sections in the CMC sections of regulatory submissions, internal and vendor reports. 

Please complete the application below and include the following attachments:

• Cover Letter
• CV / Resume
• Research Summary (if applicable)

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection.

Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta’s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta’s operations. Please visit www.enanta.com for more information.

Enanta Pharmaceuticals is an equal opportunity employer (EOE) with a commitment to diversity. All individuals, regardless of personal characteristics, are encouraged to apply. All qualified applicants will receive consideration for employment without regard to race, color, national origin, age, religious creed, gender, gender identity, sexual orientation, physical or mental disability, protected veteran status, or any other class protected by law.

Department: Formulation
This is a full time position